EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

Abstract Background Overexpression of the EVI1 (ecotropic viral integration site 1) oncogene has recently been implicated as a prognostic factor in breast cancer (BC), particularly in triple-negative BC (TNBC). In this study we aimed to investigate frequency and clinical relevance of EVI1 expression...

Full description

Bibliographic Details
Main Authors: Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl, Stefan Gröschel
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Cancer
Subjects:
Breast cancer
EVI1
Neoadjuvant chemotherapy
Online Access:https://doi.org/10.1186/s12885-022-10109-1

Internet

https://doi.org/10.1186/s12885-022-10109-1

Similar Items